Industry News

Funding boosts life-sciences manufacturing in West Michigan.

Catalent and AAPS announce the five winners of its annual academic competition.

The fabrication facility will supply modular construction to the US life-science market.

The new mAb manufacturing facility in Switzerland will supply material for clinical development.

USP and USAID give prequalification status to Capreomycin, an anti-tuberculosis injectable.

Cellectis enters an agreement with CELLforCURE for cGMP clinical manufacturing of allogeneic T-cells.

Xcelience opens a clinical packaging and distribution facility in Birmingham, UK.

APIC provides guidance on cleaning validation in API plants and how to implement GDP for APIs.

Eleven new organizations join the global "Fight the Fakes" campaign.

Malvern Instruments will acquire the MicroCal business from GE Healthcare Life Sciences.

Alexion initiates a voluntary nationwide recall of certain lots of soliris (eculizumab) concentrated solution for intravenous infusion because of visible particulate matter in a single lot.

AMRI adds commercial-scale sterile injectable manufacturing capabilities with acquisition of Oso Biopharmaceuticals.

PharmaCell has finalized its purchase of the cell therapy production facility from TiGenix.

Provence Technologies? strengthens its expertise in therapeutic chemistry with acquisition of Synprosis.

Bend Research installs its first commercial-scale spray dryer at its Oregon facility.

The 11th Annual Global Biomanufacturing Study includes a global analysis of 238 biomanufacturers and 178 suppliers in 31 countries.

EquipNet announced its 15th year of supplying asset management services.

DPx Holdings B.V. donated $110,000 to more than 20 different hospitals and organizations across the globe.

The EDQM grants Gnosis a CEP for teicoplanin, a true fermentation glycopeptide antibiotic produced by actinoplanes teichomyceticus strains.

The Philippines pharmaceutical market value is expected to increase from approximately $4.3 billion in 2013 to $8 billion by 2020.

Avantor Performance Materials appoints Michael Stubblefield as CEO.

GE Healthcare launches the Xuri IL-2 for the activation and expansion of T-lymphocytes.

PhRMA announces 119 new medicines are in development to treat mental and addictive disorders.

Brookfield continues to supply viscometers and rheometers for laboratory and on-line process control applications.

SAFC offers commercial and pilot-scale continuous-flow capacity.

Meissner moves into its new headquarters in Camarillo, California.

Hospira has recalled one lot of labetalol hydrochloride injection, USP, due to visible particulates.

SGS makes two senior appointments at its new GMP/GLP laboratory in Carson, California.

Advanced Scientifics and Chemic Laboratories enter a three-year joint cooperation agreement to collaborate on product development projects.

Hillary Clinton will deliver a keynote address at the 2014 BIO International Convention in San Diego.